CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,724,000 | +66173.8% | 1,124,714 | -5.2% | 0.00% | 0.0% |
| Q4 2022 | $7,128 | -99.9% | 1,186,030 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $6,630,000 | -5.2% | 1,139,110 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $6,996,000 | +38766.7% | 1,171,774 | +30162.8% | 0.00% | – |
| Q1 2022 | $18,000 | -14.3% | 3,872 | -53.4% | 0.00% | – |
| Q4 2021 | $21,000 | 0.0% | 8,303 | +14.0% | 0.00% | – |
| Q3 2021 | $21,000 | -12.5% | 7,283 | -23.7% | 0.00% | – |
| Q2 2021 | $24,000 | +9.1% | 9,539 | +25.5% | 0.00% | – |
| Q1 2021 | $22,000 | -18.5% | 7,601 | -10.6% | 0.00% | – |
| Q4 2020 | $27,000 | +200.0% | 8,500 | -0.4% | 0.00% | – |
| Q3 2020 | $9,000 | -10.0% | 8,538 | -0.0% | 0.00% | – |
| Q2 2020 | $10,000 | +25.0% | 8,539 | +0.5% | 0.00% | – |
| Q1 2020 | $8,000 | -96.9% | 8,500 | -94.7% | 0.00% | – |
| Q4 2019 | $255,000 | +4.9% | 161,661 | -44.5% | 0.00% | – |
| Q3 2019 | $243,000 | -23.6% | 291,481 | -22.0% | 0.00% | – |
| Q2 2019 | $318,000 | -18.9% | 373,867 | -7.6% | 0.00% | – |
| Q1 2019 | $392,000 | +26.5% | 404,477 | -4.0% | 0.00% | – |
| Q4 2018 | $310,000 | -74.8% | 421,492 | -25.9% | 0.00% | – |
| Q3 2018 | $1,229,000 | -27.1% | 568,732 | +68.1% | 0.00% | – |
| Q2 2018 | $1,685,000 | +61.4% | 338,346 | +26.4% | 0.00% | – |
| Q1 2018 | $1,044,000 | +260.0% | 267,752 | +147.2% | 0.00% | – |
| Q4 2017 | $290,000 | +6.6% | 108,313 | +26.8% | 0.00% | – |
| Q3 2017 | $272,000 | +750.0% | 85,448 | +1015.2% | 0.00% | – |
| Q1 2017 | $32,000 | – | 7,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|